SøKE ETTER NAVN:
A B C D E F G H I J K L M N O P R S T U V W X Y Z
Sprycel

Generic Sprycel (Dasatinib)

Sprycel, with the active ingredient Dasatinib, is a targeted therapy for Philadelphia chromosome-positive CML and ALL. It works by blocking cancer-causing proteins, helping to stop the growth of abnormal cells. The drug is taken orally and requires close monitoring due to its potential for serious side effects. Sprycel offers an effective treatment option for certain types of leukemia.
Velg Doser: 50mg
50mg
1flaske
Sprycel $239.99
$199.99
$199.99 per flaske
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
LEGG TIL I HANDLEKURVEN
spare: $0.00
50mg
2flasker
Sprycel $436.79
$363.99
$182.00 per flaske
+ Gratis standard luftpost tjeneste
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
LEGG TIL I HANDLEKURVEN
spare: $35.98
50mg
3flasker
Sprycel $611.99
$509.99
$170.00 per flaske
+ Gratis standard luftpost tjeneste
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
LEGG TIL I HANDLEKURVEN
spare: $89.97
Din bestilling vil bli pakket trygt og sikkert, og normalt innen 24 timer. Dette er nøyaktig hvordan pakken vil se ut (bilder av en ekte leveranse). Den har en størrelse og en utseende som et vanlig privat brev (9.4x4.3x0.3 tommer eller 24x11x0.7cm) og det avslører ikke innholdet
Du bestiller
I dag
20
June
leveringsperioden
Fri
20
Jun
Sat
21
Jun
Sun
22
Jun
Mon
23
Jun
Tue
24
Jun
Wed
25
Jun
Thu
26
Jun
Fri
27
Jun
Sat
28
Jun
Sun
29
Jun
Mon
30
Jun
Tue
01
Jul
Wed
02
Jul
Thu
03
Jul
leveringsperioden
Fri
20
Jun
Sat
21
Jun
Sun
22
Jun
Mon
23
Jun
Tue
24
Jun
Wed
25
Jun
Thu
26
Jun
Fri
27
Jun
Sat
28
Jun
Land Leveringsmåte Leveringstid Pris  
Levering 14-21 dager 10$ Sporing # tilgjengelig i 4 dager
Levering 9-14 dager 30$ Sporing # tilgjengelig i 2 dager
Frakt over hele verden Konfidensialitet og anonymitet garanti
Trygt og sikkert Diskrete pakker
Afsendelse af ordrer indenfor 24 timer 100% levering success
Attester Produktbeskrivelse
Det er ingen tilbakemeldinger for dette produktet for øyeblikket, men du kan være den første til å legge til en ellers kan du lese mer på tilbakemeldingssiden om relaterte produkter .
Legg Til Anmeldelse

Common Use

Sprycel is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive. It works by blocking the action of BCR-ABL and other tyrosine kinases that drive cancer cell growth.

Dosage and Direction

Take Sprycel exactly as prescribed by your doctor, usually once daily with or without food. Swallow the tablet whole; do not crush, split, or chew it.

Precautions

Before using Sprycel, inform your doctor if you have heart problems, lung disease, or liver issues. Regular monitoring of blood counts and organ function is required during treatment.

Contraindications

Do not use Sprycel if you are allergic to dasatinib or any of its components. Use with caution in patients with bleeding disorders or severe pulmonary conditions.

Possible Side Effect

Common side effects include fatigue, fluid retention, nausea, and diarrhea. Serious side effects may include pulmonary arterial hypertension, low blood counts, or bleeding complications.

Drug Interaction

Avoid taking Sprycel with strong CYP3A4 inhibitors or inducers, and do not consume grapefruit products. Acid-reducing agents may also interfere with drug absorption.

Missed Dose

If you miss a dose, take it as soon as you remember. If it's close to the time of your next dose, skip the missed one—do not take a double dose.

Overdose

Symptoms of overdose may include severe fatigue, low blood counts, or abnormal heart rhythms. Seek immediate medical help if an overdose is suspected.

Storage

Store Sprycel at room temperature away from moisture and light. Keep it in the original container and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.